Next Generation News and Research

RSS

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec, Inc. today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both GenVec's proprietary gene delivery platform and TheraBiologics' proprietary neural stem cell (NSC) technology.

23 Mar 2015

UF pharmacy dean to be honored with 2015 SURA Distinguished Scientist Award

SURA today announced that Julie A. Johnson, Dean and Distinguished Professor at the University of Florida's College of Pharmacy, will receive its 2015 SURA Distinguished Scientist Award.

20 Mar 2015

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Semler Scientific, Inc., an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced receipt of 510(k) marketing clearance from the U.S. Food and Drug Administration for its next generation peripheral artery disease (PAD) testing system.

19 Mar 2015

Winners of first SSPC National Crystal Growing Competition announced

The Synthesis and Solid State Pharmaceutical Centre today (19th March 2015) announced the winners of its first SSPC National Crystal Growing Competition, which was launched as part of Science Week in November 2014, to celebrate the International Year of Crystallography. The SSPC National Crystal Growing Competition was open to primary and post-primary schools from across Ireland.

19 Mar 2015

Manchester scientists develop enhanced surface for silicone breast implants

Scientists at The University of Manchester have created an enhanced surface for silicone breast implants which could reduce complications and make them less likely to be rejected by the body.

19 Mar 2015

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab.

19 Mar 2015

Envy Medical launches world-class patented Advanced Dermalinfusion Technology

Envy Medical, Inc. launches SilkPeel3, the next generation of its world class patented Advanced Dermalinfusion Technology. Unveiled originally in 2005, SilkPeel is celebrating its 10th birthday in style with fresh features, enhanced functionality and a sleek new design.

18 Mar 2015

DNA sequence determines flexibility, stability of DNA package inside microscopic cell

To pack two meters of DNA into a microscopic cell, the string of genetic information must be wound extremely carefully into chromosomes. Surprisingly the DNA's sequence causes it to be coiled and uncoiled much like a yoyo, scientists reported in Cell.

18 Mar 2015

New initiative launched to educate nurses, physicians to improve health and health care

The University of Michigan, University of California Los Angeles, University of Pennsylvania and Yale University have teamed up to launch a new initiative to educate nurses and physicians together to serve as leaders, researchers and change agents in health care, community health and public policy.

17 Mar 2015

Ruthigen, Pulmatrix sign definitive merger agreement

Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.

16 Mar 2015

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.

16 Mar 2015

New immunotoxin found to be safe, effective in patients with B-cell malignancies

Almost all patients with a group of blood cancers called B-cell malignancies have two prominent "fingerprints" on the surface of leukemia and lymphoma cancers, called CD22 and CD19, Vallera explained.

13 Mar 2015

UH professor part of personalized medicine panel session at SXSW Health and MedTech Expo

University of Houston professor Preethi Gunaratne will be part of a panel addressing personalized medicine at the South by Southwest (SXSW) Health and MedTech Expo in Austin Tuesday, March 17.

13 Mar 2015

Pressure BioSciences introduces PCT-HD System to global proteomics market

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced the commercial release of the PCT-HD system.

12 Mar 2015

Next Generation News and Research

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

UF pharmacy dean to be honored with 2015 SURA Distinguished Scientist Award

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Winners of first SSPC National Crystal Growing Competition announced

Manchester scientists develop enhanced surface for silicone breast implants

Janssen announces acquisition of XO1

Envy Medical launches world-class patented Advanced Dermalinfusion Technology

DNA sequence determines flexibility, stability of DNA package inside microscopic cell

New initiative launched to educate nurses, physicians to improve health and health care

Ruthigen, Pulmatrix sign definitive merger agreement

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

New immunotoxin found to be safe, effective in patients with B-cell malignancies

UH professor part of personalized medicine panel session at SXSW Health and MedTech Expo

Pressure BioSciences introduces PCT-HD System to global proteomics market

TSRI chemists develop innovative method for building new drug molecules

Understanding the role of next generation sequencing in stratified cancer medicine

New medical innovations to be presented at Royal Society of Medicine summit

Quest Diagnostics to provide whole exome sequencing service to diagnose neurological disorders

Afterschool programs help improve kids' health and physical fitness

Loyola's Genomics Facility uses next generation sequencing to study genetic make-up of organisms

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News